Researchers model familial amyloidosis in vitro using iPSC technology
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have generated the first known disease-specific induced pluripotent stem cell (iPSC) lines from a patient with familial transthyretin ...
Oct 31, 2013
0
0